Abstract:Abstract Background: Cell-type-specific super enhancers, or large clusters of mediator-rich enhancers, are highly transcribed regions of the genome with key functions in the maintenance of cell identity and control. These regulatory elements are easily perturbed and enriched for disease-associated sequence variation. Identification of disease-associated super-enhancers and investigation of their sequence variants may help identify important, biologically relevant associations previously overlooked by genome-wide studies. Thus, we sought to identify variants within ovarian tissue specific super-enhancers and investigate their association with epithelial ovarian cancer (EOC) susceptibility. Methods: We utilized genotype data from a European population of ∼11,000 invasive EOC cases and 22,000 healthy controls from the Ovarian Cancer Association Consortium. A public catalog of 478 super-enhancers, identified by peak histone H3K27ac ChIP-seq signal in ovarian tissue, was used to identify 72,116 variants located within 344 super-enhancer regions. Unconditional logistic regression (log-additive model) was used to assess individual SNP-EOC risk associations. Additionally, we reviewed associations within 500 kb of super-enhancer regions to identify proximal associated variants. When LD structure indicated, we employed conditional analysis to determine independence of the super-enhancer signal. Gene-EOC risk associations were assessed with the Admixture Maximum Likelihood (AML) test and Sequence-Kernel Association Test (SKAT) for the combined effect of common and rare (MAF<0.01) variants. Models were adjusted for population stratification using the first five principal components. To adjust for multiple comparisons, a false discovery rate of 10% was used. Results: The most significant SNP observed was rs147487657 (p = 7.7×10−6) on locus 2q37.3 in the HDAC4 gene and there were an additional 12 SNPs with p<1.0×10−4, although not significant at 10% FDR. Gene-level analyses identified two super-enhancers significantly associated with EOC risk. An enhancer at the previously reported 2q31 locus, containing HOXD8 and HOXD-AS2, associated (SKAT p = 4.3×10−5; AML p<0.001) with the top SNP located within the 5′UTR of HOXD8 transcription factor (rs847163 (T>C); p<2.08×10−5). Conditional analysis did not identify an independent association within the super-enhancer region. The second EOC-associated super-enhancer identified was at locus 1q32 (SKAT p = 0.00052, AML p = 0.001) containing the CSRP1 gene. There were 6 SNPs with p<0.001 and 16 SNPs with p<0.01, all were inversely associated with risk and consistent with the top hit at rs927901 T>C (OR = 0.94; 95% CI: 0.90-0.97; p = 2.1×10−4). Associations varied by histologic subtype, possibly due to variance in disease relevant super-enhancer cell-type.Conclusion: These findings suggest germline variation within super-enhancer regions may contribute to EOC susceptibility Citation Format: Brett M. Reid, Jennifer Permuth-Wey, Y. Ann Chen, Hui-Yi Lin, Alvaro Monteiro, Zhihua Chen, Andrew Berchuck, Georgia Chenevix-Trench, Jennifer Doherty, Simon Gayther, Ellen L. Goode, Edwin Iversen, Leigh Pearce, Paul Pharoah, Catherine Phelan, Susan Ramus, Mary Anne Rossing, Joellen Schildkraut, Thomas Sellers, on behalf of the Ovarian Cancer Association Consortium. Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4634. doi:10.1158/1538-7445.AM2015-4634

Abstract LB-336: Association of Variant Rs2046210 at 6q25.1 (ESR1) with Breast Cancer Risk Suggests Heterogeneity by E-cadherin Tumor Tissue Expression

Abstract 4634: Variants Within Super-Enhancer Regulatory Elements Associate with Epithelial Ovarian Cancer Risk

Abstract 4633: Evidence That Long Non-Coding RNA Variants Associate with Epithelial Ovarian Cancer Risk

Candidate Locus Analysis of the TERT – CLPTM1L Cancer Risk Region on Chromosome 5p15 Identifies Multiple Independent Variants Associated with Endometrial Cancer Risk

Nucleotide Excision Repair Gene ERCC1 19007T>C Polymorphism Contributes to Lung Cancer Susceptibility: A Meta-Analysis

Identification and Molecular Characterization of a New Ovarian Cancer Susceptibility Locus at 17Q21.31.

Microrna Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

Exome Genotyping Arrays to Identify Rare and Low Frequency Variants Associated with Epithelial Ovarian Cancer Risk.

Abstract 4579: Variants in Long Non-Coding RNAs Are Associated with Epithelial Ovarian Cancer Risk in a Pooled Analysis of Three Genome-Wide Association Studies.

Association Between a Novel Polymorphism (rs2046210) of the 6q25.1 Locus and Breast Cancer Risk

Quantitative Assessment of the Association Between Rs2046210 at 6q25.1 and Breast Cancer Risk.

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

Fine-mapping of the HNF1B Multicancer Locus Identifies Candidate Variants That Mediate Endometrial Cancer Risk.

Association of Three Single Nucleotide Polymorphisms of ESR1 with Breast Cancer Susceptibility: a Meta-Analysis

Abstract 221: Inherited Variants at 3q13.33 and 3p24.1 Influences Risk of Diffuse Large B-cell Lymphoma

Relationship Between ESR1 Gene Polymorphisms and Breast Cancer Susceptibility

A Meta-Analysis of the Association Between ESR 1 Genetic Variants and the Risk of Breast Cancer

Abstract 1349: Genetic Variants in DNA Repair Pathway Genes Are Associated with the Risk of Esophageal Adenocarcinoma.

Abstract 1340: Identification of Epidermal Growth Factor Receptor (EGFR) Polymorphisms That Modify Risk for Squamous Cell Carcinoma of the Head and Neck (HNSCC).

rs77283072 influences breast cancer susceptibility by regulating CDKN2A expression